Aromatase Inhibitors as First Line Treatment: Treatment Cascade After Failure of Aromatase Inhibitors

Author： Bonneterre Jacques  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.81, Iss.1, 2003-01, pp. : 57-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase Inhibitors for Treatment of Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 67-79

Bentham Science Publishers

Access to resources Recommend Favorite

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

By Riemsma Rob  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 9-24

Springer Publishing Company

Access to resources Recommend Favorite

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen

By Ramirez-Ardila Diana  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 39-49

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitors in the treatment of early and advanced breast cancer

By Joensuu Heikki   Ejlertsen Bent   Lønning Per   Rutqvist Lars-Erik  

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 54-65

Bentham Science Publishers

Access to resources Recommend Favorite